Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Charged multivesicular body protein 1A pseudogene 1 (CHMP1AP1) is a pseudogene—an inactive segment of DNA that resembles a protein-coding gene but generally contains mutations preventing it from producing a functional protein[1][8]. Pseudogenes are categorized by their origin, such as duplication, retrotransposition, or mutations within a gene that render it nonfunctional[2][8]. Most pseudogenes, including CHMP1AP1, do not have an established biological function or role in disease, and they are not targets for known drugs[1][4]. Some pseudogenes in general can influence gene regulation at the RNA level (e.g., via miRNA decoy effects), but there is no evidence for this with CHMP1AP1 specifically[2][7]. Given current evidence, CHMP1AP1 is not a drug target and has no known functional role or implication in disease or therapy. It remains an example of a genomic sequence of evolutionary interest but does not meet the criteria for structured therapeutic target annotation[1][4][8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Charged multivesicular body protein 1A pseudogene 1 (CHMP1AP1).